TNFRSF11B and rheumatoid arthritis: Osteoprotegerin (OPG) has a bone-protective effect by inhibiting downstream signaling of RANKL in osteoclasts, and a decrease in OPG levels has been observed in patients with acute rheumatoid arthritis.